Risk factors and outcome of COVID-19 in patients with hematological malignancies

被引：0

作者：

José Luis Piñana

Rodrigo Martino

Irene García-García

Rocío Parody

María Dolores Morales

Gonzalo Benzo

Irene Gómez-Catalan

Rosa Coll

Ignacio De La Fuente

Alejandro Luna

Beatriz Merchán

Anabelle Chinea

Dunia de Miguel

Ana Serrano

Carmen Pérez

Carola Diaz

José Luis Lopez

Adolfo Jesús Saez

Rebeca Bailen

Teresa Zudaire

Diana Martínez

Manuel Jurado

María Calbacho

Lourdes Vázquez

Irene Garcia-Cadenas

Laura Fox

Ana I. Pimentel

Guiomar Bautista

Agustin Nieto

Pascual Fernandez

Juan Carlos Vallejo

Carlos Solano

Marta Valero

Ildefonso Espigado

Raquel Saldaña

Luisa Sisinni

Josep Maria Ribera

Maria Jose Jimenez

Maria Trabazo

Marta Gonzalez-Vicent

Noemí Fernández

Carme Talarn

Maria Carmen Montoya

Angel Cedillo

Anna Sureda

机构：

[1] Hospital Universitario y Politécnico La Fe,Hematology División

[2] Instituto de Investigación Sanitaria La Fe,Hematology División

[3] CIBERONC,Hematology División

[4] Instituto Carlos III,Hematology División

[5] Hospital de la Santa Creu i Sant Pau,Hematology División

[6] Hospital Ramon y Cajal,Hematology División

[7] Institut Català Oncologia-Hospital Duran i Reynals,Hematology División

[8] Hospital de Guadalajara,Hematology División

[9] Hospital La Princesa,Hematology División

[10] Hospital de Albacete,Hematology División

[11] Institut Català Oncologia-Hospital Josep Trueta,Hematology División

[12] Hospital Clínico de Valladolid,Hematology División

[13] Hospital Carlos Haya,Hematology División

[14] Hospital Fundación Jiménez Díaz,Hematology División

[15] Hospital Gregorio Marañon,Hematology División

[16] Hospital de Navarra,Hematology División

[17] Hospital a Coruña,Hematology División

[18] Hospital Virgen de la Nieves,Hematology División

[19] Hematology División,Hematology División

[20] Hospital Universitario de Salamanca,Hematology División

[21] Hospital Vall d`Hebron,Hematology División

[22] Hospital Clínico Universitario Lozano Blesa,Hematology División

[23] IIS Aragon,Hematology División

[24] Hospital Puerta de Hierro,Hematology División

[25] Hospital de Vigo,Department of Hematology

[26] Hospital General de Alicante,Hematology División

[27] Hospital de Donostia,Pediatric Hematology

[28] Hospital Clínico Universitario de Valencia,Oncology División

[29] Hospital Arnau de Vilanova,Hematology División

[30] University Hospital Virgen del Rocío/University of Sevilla,Pediatric División

[31] CSIC/Institute of Biomedicine of Sevilla,Pediatric División

[32] Hospital de Jerez,Hematology División

[33] Hospital la Paz,Hematology División

[34] ICO-Hospital Germans Trias i Pujol,Division of Clinical Hematology

[35] Josep Carreras Research Institute,undefined

[36] Hospital de la Santa Creu i Sant Pau,undefined

[37] Hospital niño Jesús,undefined

[38] Hospital Marqués de Valdecilla,undefined

[39] Hospital Joan XXIII,undefined

[40] Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH),undefined

[41] Hospital Universitario la Fe de Valencia,undefined

[42] Avda Fernando Abril Martorell,undefined

来源：

Experimental Hematology & Oncology | / 9卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Risk factors and outcome of COVID-19 in patients with hematological malignancies
Pinana, Jose Luis
Martino, Rodrigo
Garcia-Garcia, Irene
Parody, Rocio
Morales, Maria Dolores
Benzo, Gonzalo
Gomez-Catalan, Irene
Coll, Rosa
De la Fuente, Ignacio
Luna, Alejandro
Merchan, Beatriz
Chinea, Anabelle
de Miguel, Dunia
Serrano, Ana
Perez, Carmen
Diaz, Carola
Lopez, Jose Luis
Saez, Adolfo Jesus
Bailen, Rebeca
Zudaire, Teresa
Martinez, Diana
Jurado, Manuel
Calbacho, Maria
Vazquez, Lourdes
Garcia-Cadenas, Irene
Fox, Laura
Pimentel, Ana I.
Bautista, Guiomar
Nieto, Agustin
Fernandez, Pascual
Vallejo, Juan Carlos
Solano, Carlos
Valero, Marta
Espigado, Ildefonso
Saldana, Raquel
Sisinni, Luisa
Ribera, Josep Maria
Jimenez, Maria Jose
Trabazo, Maria
Gonzalez-Vicent, Marta
Fernandez, Noemi
Talarn, Carme
Montoya, Maria Carmen
Cedillo, Angel
Sureda, Anna
[J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2020, 9 (01)
[2] Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies
Wu, Tzong-Yow
Tsai, Wan-Ting
Chen, Kai-Hsiang
Huang, Szu-Ting
Huang, Chun-Fu
Kuo, Po-Hsien
Tsai, Ming-Jui
Liu, Wang-Da
Lin, Kuan-Yin
Huang, Yu-Shan
Cheng, Aristine
Chen, Pao-Yu
Sun, Hsin-Yun
Huang, Huai-Hsuan
Huang, Tai-Chung
Wu, Shang-Ju
Yao, Ming
Wang, Jann-Tay
Sheng, Wang-Huei
Hung, Chien-Ching
Chen, Yee-Chun
Chang, Shan-Chwen
[J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2024, 57 (03) : 403 - 413
[3] A Comparative Outcome Analysis of COVID-19 and Influenza Infection in Patients with Hematological Malignancies
Ghandili, Susanne
Niederwieser, Christian
Weisel, Katja
Bokemeyer, Carsten
Fiedler, Walter
Modemann, Franziska
[J]. BLOOD, 2021, 138
[4] COVID-19 IN HEMATOLOGICAL MALIGNANCIES
Passamonti, F.
[J]. HAEMATOLOGICA, 2021, 106 (10) : 231 - 232
[5] Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies
Borah, Pronamee
Mirgh, Sumeet
Sharma, Sanjeev Kumar
Bansal, Sachin
Dixit, Ashish
Dolai, Tuphan Kanti
Lunkad, Sweta
Gupta, Naveen
Singh, Gurmeet
Jain, Aditi
Bansal, Divya
Choudhary, Dharma
Khandelwal, Vipin
Doval, Divya
Kumar, Meet
Bhargava, Rahul
Chakrabarti, Amrita
Kalashetty, Mallikarjun
Rauthan, Amit
Kazi, Bilal
Mandal, Prakas Kumar
Jeyaraman, Preethi
Naithani, Rahul
[J]. BLOOD CELLS MOLECULES AND DISEASES, 2021, 87
[6] The outcome of COVID-19 in patients with hematological malignancy
Yigenoglu, Tugce N.
Ata, Naim
Altuntas, Fevzi
Basci, Semih
Dal, Mehmet Sinan
Korkmaz, Serdal
Namdaroglu, Sinem
Basturk, Abdulkadir
Hacibekiroglu, Tuba
Dogu, Mehmet H.
Dal, Kursat
Erkurt, Mehmet A.
Turgut, Burhan
Ulgu, Mustafa Mahir
Celik, Osman
Imrat, Ersan
Birinci, Suayip
[J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 1099 - 1104
[7] The outcome of COVID-19 in patients with hematological malignancy
Tiglioglu, Pinar
Albayrak, Murat
Tiglioglu, Mesut
Ozturk, Hacer Berna Afacan
Aras, Merih Reis
Saglam, Bugra
Maral, Senem
[J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (01) : 83 - 89
[8] The outcome of COVID-19 in patients with hematological malignancy
Pınar Tığlıoğlu
Murat Albayrak
Mesut Tığlıoğlu
Hacer Berna Afacan Öztürk
Merih Reis Aras
Buğra Sağlam
Senem Maral
[J]. memo - Magazine of European Medical Oncology, 2022, 15 : 83 - 89
[9] The outcome of COVID-19 in patients with hematological malignancy
Yigenoglu, Tugce N.
Basci, Semih
Dal, Mehmet S.
Korkmaz, Serdal
Turgut, Burhan
Altuntas, Fevzi
[J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1255 - 1255
[10] The course of COVID-19 in patients with hematological malignancies and risk factors affecting mortality: A cross-sectional study
Eryilmaz-Eren, Esma
Ture, Zeynep
Kilinc-Toker, Aysin
Korkmaz, Serdal
Celik, Ilhami
[J]. HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (01) : 3 - 7

← 1 2 3 4 5 →